---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-021763"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:47:12.134513+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Vor Biopharma reprices 6.76M underwater stock options to $1.34 per share

## Summary
- Board reduces exercise price to $1.34 for options with original prices from $1.36 to $44.96.
- Repricing applies to continuing employees; CEO's 2.13M options repriced (avg $4.30).
- Options may not be exercised at reduced price before February 3, 2026 retention end.
- CSO Tirtha Chakraborty and CMO Eyal Attar also have options repriced.
- Move intended to retain and motivate employees without additional equity or cash.

## SEC filing metadata
- accession: 0001193125-25-021763
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312525021763/0001193125-25-021763-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525021763/d921842d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-021763
- JSON: https://secwatch.observer/filing/0001193125-25-021763.json
- Plain text: https://secwatch.observer/filing/0001193125-25-021763.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.